T1D patients, treated with insulin for several years, had increased cerebrospinal fluid (CSF) concentrations of soluble low density lipoprotein receptor-related protein (LRP1) [93] that promoted the removal of Aβ from the brain. This evidence concerns the gene INS and type 1 diabetes mellitus.